INMUNE BIO, INC.

Profile

Company Names

INMUNE BIO, INC.

Addresses

1224 PROSPECT STREET, SUITE 150, LA JOLLA, CA 92037

1224 PROSPECT STREET, SUITE 150, LA JOLLA, CA 92037

Phone Numbers

(858) 964-3720

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

NEVADA

Total Amount Raised:

$8,039,904.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-04-29 
$4,699,904.00 
$4,699,904.00 
$0.00 
Equity 
1
2017-03-15 
$3,340,000.00 
$5,000,000.00 
$1,660,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
J. 
KELLY 
GANJEI 
DIRECTOR
INMUNE BIO, INC.
SCOTT 
 
JUDA 
DIRECTOR
FOSSICK CAPITAL PARTNERS, LP   |  INMUNE BIO, INC.
TERRY 
R. 
KNAPP 
DIRECTOR
MAGELLAN GLOBAL HEALTH, INC.   |  INMUNE BIO, INC.
MARK 
 
LOWDELL 
EXECUTIVE OFFICER, DIRECTOR
INMUNE BIO, INC.
DAVID 
J. 
MOSS 
EXECUTIVE OFFICER, DIRECTOR
INMUNE BIO, INC.
TIMOTHY 
 
SCHROEDER 
DIRECTOR
PERFORMANCE COMMUNITIES, LLC   |  INMUNE BIO, INC.
DAVID 
 
SZYMKOWSKI 
DIRECTOR
INMUNE BIO, INC.
RAYMOND 
J. 
TESI 
EXECUTIVE OFFICER, DIRECTOR
CORONADO BIOSCIENCES INC   |  INMUNE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-05-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-04-29 
2017-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
WESTPARK CAPITAL, INC.
39914
WESTPARK CAPITAL, INC.
39914